Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Yasumasa Nishimura

Department of Radiation Oncology

Kinki University Faculty of Medicine

377-2

Ohno-Higashi

Japan

[email]@med.kindai.ac.jp

Name/email consistency: high

[Claim this account]

Affiliation

Department of Radiation Oncology, Kinki University Faculty of Medicine, 377-2, Ohno-Higashi, Japan. 2000 - 2012

References

Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021). Nishimura, Y., Hiraoka, M., Koike, R., Nakamatsu, K., Itasaka, S., Kawamura, M., Negoro, Y., Araki, N., Ishikawa, H., Fujii, T., Mitsuhashi, N. Jpn. J. Clin. Oncol. (2012) [Pubmed]
Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Nishimura, Y., Koike, R., Ogawa, K., Sasamoto, R., Murakami, Y., Itoh, Y., Negoro, Y., Itasaka, S., Sakayauchi, T., Tamamoto, T. Int. J. Clin. Oncol. (2011) [Pubmed]
A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the Kinki University experience. Nishimura, Y., Shibata, T., Nakamatsu, K., Kanamori, S., Koike, R., Okubo, M., Nishikawa, T., Tachibana, I., Tamura, M., Okumura, M. Jpn. J. Clin. Oncol. (2010) [Pubmed]
A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021). Nishimura, Y., Mitsumori, M., Hiraoka, M., Koike, R., Nakamatsu, K., Kawamura, M., Negoro, Y., Fujiwara, K., Sakurai, H., Mitsuhashi, N. Radiother. Oncol (2009) [Pubmed]
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002). Nishimura, Y., Nakagawa, K., Takeda, K., Tanaka, M., Segawa, Y., Tsujino, K., Negoro, S., Fuwa, N., Hida, T., Kawahara, M., Katakami, N., Hirokawa, K., Yamamoto, N., Fukuoka, M., Ariyoshi, Y. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. Nishimura, Y., Nakamatsu, K., Shibata, T., Kanamori, S., Koike, R., Okumura, M., Suzuki, M. Jpn. J. Clin. Oncol. (2005) [Pubmed]
Rationale for chemoradiotherapy. Nishimura, Y. Int. J. Clin. Oncol. (2004) [Pubmed]
Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer. Nishimura, Y., Koike, R., Nakamatsu, K., Kanamori, S., Suzuki, M., Shigeoka, H., Shiozaki, H. Jpn. J. Clin. Oncol. (2003) [Pubmed]
Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Nishimura, Y., Suzuki, M., Nakamatsu, K., Kanamori, S., Yagyu, Y., Shigeoka, H. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
Long-term results of fractionated strontium-90 radiation therapy for pterygia. Nishimura, Y., Nakai, A., Yoshimasu, T., Yagyu, Y., Nakamatsu, K., Shindo, H., Ishida, O. Int. J. Radiat. Oncol. Biol. Phys. (2000) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.